Plus Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Plus Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 2093% to $4,913,000. The net income raised on -$13,316,000 and profit margin reached -271%. Total operating expenses were $8,544,000.
Profit Margin
| 2014 | 7.59M | -37.36M | -491.81% |
|---|---|---|---|
| 2015 | 11.65M | -18.74M | -160.77% |
| 2016 | 11.38M | -22.04M | -193.73% |
| 2017 | 6.41M | -22.68M | -353.86% |
| 2018 | 2.98M | -12.63M | -423.53% |
| 2019 | 6.99M | -12.74M | -182.08% |
| 2020 | 303K | -9.34M | -3085.15% |
| 2021 | 0 | -14.33M | |
| 2022 | 224K | -20.83M | -9302.68% |
| 2023 | 4.91M | -13.31M | -271.04% |
PSTV Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 4.91M | 224K | 0 | 303K | 6.99M | 2.98M | 6.41M | 11.38M | 11.65M | 7.59M |
Cost of revenue | 9.69M | 712K | 66K | 2.7M | 5.36M | 1.14M | 1.31M | 2.71M | 3.18M | 2.94M |
Gross profit | -4.77M | -488K | -66K | -2.39M | 1.63M | 1.83M | 5.09M | 8.66M | 8.47M | 4.65M |
Operating exp. | ||||||||||
Research and development | 9.69M | 9.69M | 5.57M | 3.48M | 5.36M | 5.52M | 13.36M | 16.19M | 19M | 15.10M |
Selling and marketing | 0 | 0 | 0 | 0 | 468K | 643K | 3.59M | 3.61M | 2.66M | 6.40M |
Total operating expenses | 8.54M | 19.93M | 12.42M | 9.88M | 10.65M | 11.74M | 25.77M | 28.37M | 31.42M | 37.46M |
Operating income | -13.32M | -19.71M | -12.49M | -9.58M | -3.65M | -8.76M | -20.68M | -19.70M | -15.28M | -32.43M |
Other income (expenses), net | 5K | -563K | -907K | 1.34M | 374K | 1.76M | -2.00M | 233K | -3.45M | -4.93M |
Income before tax | -13.31M | -20.27M | -13.39M | -8.24M | -3.28M | -8.87M | -22.68M | -22.04M | -18.74M | -37.36M |
Income tax expense | 0 | 563K | 932K | 1.10M | 9.45M | 1.98M | 2.06M | 2.82M | 3.54M | 3.76M |
Net income | -13.31M | -20.83M | -14.33M | -9.34M | -12.74M | -12.63M | -22.68M | -22.04M | -18.74M | -37.36M |
Earnings per share | ||||||||||
Basic EPS | -4.24 | -11.91 | -17.78 | -31.67 | -138.1 | -1.09K | -5.25K | -9.56K | -14.98K | -40.31K |
Diluted EPS | -4.24 | -11.91 | -17.78 | -31.67 | -138.1 | -1.09K | -5.25K | -9.56K | -14.98K | -40.31K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |